Nuwellis, Inc.NN

Nuwellis, Inc.

0.9170USDR
+0.0170+1.89%
At close at May 22, 23:37 GMT
USD
No trades
See on Supercharts
Next report date
August 12
Report period
Q2 2025
EPS estimate
−0.45 USD
Revenue estimate
‪2.20 M‬ USD
Market capitalization
‪4.01 M‬USD
−18.2363USD
‪−11.16 M‬USD
‪8.74 M‬USD
‪4.37 M‬
Beta (1Y)
1.89
Employees (FY)
38
Change (1Y)
−21 −35.59%
Revenue / Employee (1Y)
‪230.00 K‬USD
Net income / Employee (1Y)
‪−293.82 K‬USD

About Nuwellis, Inc.


CEO
John L. Erb
Headquarters
Eden Prairie
Founded
1999
FIGI
BBG000QVFRH8
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Performance
‪−360%‬
‪−240%‬
‪−120%‬
‪0%‬
‪120%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−9.00 M‬‬
‪‪−6.00 M‬‬
‪‪−3.00 M‬‬
‪0.00‬
‪‪3.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−3.20 M‬‬
‪‪−1.60 M‬‬
‪0.00‬
‪‪1.60 M‬‬
‪‪3.20 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−3.20 M‬‬
‪‪−1.60 M‬‬
‪0.00‬
‪‪1.60 M‬‬
‪‪3.20 M‬‬
Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−5.20 M‬‬
‪‪−2.60 M‬‬
‪0.00‬
‪‪2.60 M‬‬
‪‪5.20 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Aug 12, 2025
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪−21.00‬
‪−14.00‬
‪−7.00‬
‪0.00‬
‪7.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NUWE is 0.9170 USD — it has increased by 1.89% in the past 24 hours. Watch Nuwellis, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Nuwellis, Inc. stocks are traded under the ticker NUWE.
NUWE stock has fallen by −9.55% compared to the previous week, the month change is a −3.23% fall, over the last year Nuwellis, Inc. has showed a −89.85% decrease.
We've gathered analysts' opinions on Nuwellis, Inc. future price: according to them, NUWE price has a max estimate of 11.00 USD and a min estimate of 11.00 USD. Watch NUWE chart and read a more detailed Nuwellis, Inc. stock forecast: see what analysts think of Nuwellis, Inc. and suggest that you do with its stocks.
NUWE reached its all-time high on Mar 1, 2012 with the price of 20,197,800,000.0000 USD, and its all-time low was 0.7506 USD and was reached on Apr 7, 2025. View more price dynamics on NUWE chart.
See other stocks reaching their highest and lowest prices.
NUWE stock is 6.33% volatile and has beta coefficient of 1.89. Track Nuwellis, Inc. stock price on the chart and check out the list of the most volatile stocks — is Nuwellis, Inc. there?
Today Nuwellis, Inc. has the market capitalization of ‪3.94 M‬, it has increased by 6.27% over the last week.
Yes, you can track Nuwellis, Inc. financials in yearly and quarterly reports right on TradingView.
Nuwellis, Inc. is going to release the next earnings report on Aug 12, 2025. Keep track of upcoming events with our Earnings Calendar.
NUWE earnings for the last quarter are −0.69 USD per share, whereas the estimation was −0.45 USD resulting in a −53.33% surprise. The estimated earnings for the next quarter are −0.45 USD per share. See more details about Nuwellis, Inc. earnings.
Nuwellis, Inc. revenue for the last quarter amounts to ‪1.90 M‬ USD, despite the estimated figure of ‪2.50 M‬ USD. In the next quarter, revenue is expected to reach ‪2.20 M‬ USD.
NUWE net income for the last quarter is ‪−3.01 M‬ USD, while the quarter before that showed ‪−1.47 M‬ USD of net income which accounts for −105.31% change. Track more Nuwellis, Inc. financial stats to get the full picture.
No, NUWE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2025, the company has 38 employees. See our rating of the largest employees — is Nuwellis, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nuwellis, Inc. EBITDA is ‪−8.99 M‬ USD, and current EBITDA margin is −122.17%. See more stats in Nuwellis, Inc. financial statements.
Like other stocks, NUWE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nuwellis, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nuwellis, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nuwellis, Inc. stock shows the sell signal. See more of Nuwellis, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.